1. Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, Marcos-Gragera R, Maynadié M, Simonetti A, Lutz JM, Berrino F (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 116(19):3724–3734
2. Kaatsch P, Grabow D, Spix C (2016) German childhood cancer registry – annual report 2016 (1980–2015). Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI) at the University Medical Center of the Johannes Gutenberg University Mainz, Mainz
3. Surveillance, Epidemiology, and End Results (SEER) Program (
www.seer.cancer.gov
) SEER*Stat Database: Incidence – SEER 13 Registries excluding AK Research Data, Nov 2015 Sub (1992–2013) National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission. Calculated with SEER*Stat software (
www.seer.cancer.gov/seerstat
) version 8.2.1
4. Australian Institute of Health and Welfare (AIHW) (2017) Australian Cancer Incidence and Mortality (ACIM) books: acute lymphoblastic leukaemia (ALL) and Acute myeloid leukaemia. AIHW, Canberra
5. De Angelis R, Minicozzi P, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A (2015) Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study. Eur J Cancer 51:2254–2268